James Budge - 10 Sep 2026 Form 4 Insider Report for Hinge Health, Inc. (HNGE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Sep 2026, 19:38:11 UTC
Prior SEC filing
02 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James Budge

Key filing fact

James Budge filed Form 4 for Hinge Health, Inc. (HNGE) on 11 Sep 2026.

Key facts

  • This page summarizes James Budge's Form 4 filing for Hinge Health, Inc. (HNGE).
  • 5 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Sep 2026, 19:38.

Change

  • Previous filing in this sequence was filed on 02 Sep 2026.
  • Current net transaction value: -$4,969,999.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001338176 Primary reporting owner

Budge James

Relationship
Chief Financial Officer
Address
C/O HINGE HEALTH, INC., 455 MARKET STREET, SUITE 700, SAN FRANCISCO
Signature
/s/ James Budge
Signature date
11 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HNGE transaction

Class A Common Stock

Sale

Transaction value
$1,169,924
Shares
-13,261
Change %
-3.3%
Price
$88.22
Shares after
391,362
Date
10 Sep 2026
Ownership
Direct
Footnotes
F1, F2
HNGE transaction

Class A Common Stock

Sale

Transaction value
$1,228,862
Shares
-13,807
Change %
-3.5%
Price
$89.00
Shares after
377,555
Date
10 Sep 2026
Ownership
Direct
Footnotes
F1, F3
HNGE transaction

Class A Common Stock

Sale

Transaction value
$1,961,516
Shares
-21,783
Change %
-5.8%
Price
$90.05
Shares after
355,772
Date
10 Sep 2026
Ownership
Direct
Footnotes
F1, F4
HNGE transaction

Class A Common Stock

Sale

Transaction value
$536,403
Shares
-5,910
Change %
-1.7%
Price
$90.76
Shares after
349,862
Date
10 Sep 2026
Ownership
Direct
Footnotes
F1, F5
HNGE transaction

Class A Common Stock

Sale

Transaction value
$73,294
Shares
-800
Change %
-0.23%
Price
$91.62
Shares after
349,062
Date
10 Sep 2026
Ownership
Direct
Footnotes
F1, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and his spouse on June 11, 2026.

Footnote F2

Represents the weighted average sale price. The lowest price at which shares were sold was $87.44 and the highest price at which shares were sold was $88.41. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Footnote F3

Represents the weighted average sale price. The lowest price at which shares were sold was $88.44 and the highest price at which shares were sold was $89.43. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Footnote F4

Represents the weighted average sale price. The lowest price at which shares were sold was $89.45 and the highest price at which shares were sold was $90.445. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Footnote F5

Represents the weighted average sale price. The lowest price at which shares were sold was $90.45 and the highest price at which shares were sold was $91.42. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Footnote F6

Represents the weighted average sale price. The lowest price at which shares were sold was $91.53 and the highest price at which shares were sold was $91.75. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .